Cipla Limited & Anr. v. Drugs Controller General of India & Anr.
Case brief
What is this about?
Batch withdrawal order, Delhi High Court, 13.01.2026, Bench: Chief Justice with Tejas Karia, J. Nineteen writ petitions dismissed as withdrawn with pending applications after counsel sought leave: W.P.(C) 8674/2023 (J D Pharma), 8675/2023 (Venus Labs), 8678/2023 (SkyMap Pharmaceuticals), 8680/2023 (Horizon Bioceuticals), 8682/2023 (Cipla Limited), 8726/2023 (Aptus Pharma), 8728/2023 (SkyMap Pharmaceuticals), 8730/2023 (Cipla Limited), 8731/2023 (Cipla Limited), 8732/2023 (Ozone Pharmaceuticals), 8747/2023 (SkyMap Pharmaceuticals), 9033/2023 (Astra Labs), 9035/2023 (Acron Pharmaceuticals), 9165/2023 (Acron Pharmaceuticals), 9391/2023 (Excel Labs), 9433/2023 (Aelix Pharma), 10466/2023 (Navnidhi Lifesciences), 10558/2023 (Solitaire Pharmacia), 683/2024 (Svizera Health Remedies LLP). Respondents: Drugs Controller General of India & Anr. / Union of India & Anr. Petitioner-side counsel: Sanjay Jain, Archana Sahadeva, Harisit, Amer Vaid. State-side: Tarveen Singh Nanda (Govt. Pleader), Rakesh Kumar (SPC), Rahul Kumar (GP), Sunil, Vineet Dhanda, Deepak Tanwar, Rajdev Kumar, Hitesh Batra. No merits adjudicated; no precedential value; not citable for any proposition of law.